The National Institutes of Health said Monday it has engaged Moderna in "good faith discussions" to resolve a monthslong dispute over the company's patent application that advocates say could impact global production of the shots.
Moderna is offering to share ownership of its COVID-19 vaccine patent with the U.S. government to resolve the dispute, the vaccine maker said, and would allow the Biden administration to "license the patents as they see fit."
An NIH spokesperson declined Monday to comment directly on Moderna's offer, citing "ongoing discussions."
The company claims it had no choice under the "strict rules" of American patent law to list only its own scientists "as the inventors on these claims."
But the National Institute of Allergy and Infectious Diseases disagrees.
read more:
Replies
It only matters if one plans on using it. I don't. If you don't, it doesn't matter.
Lynn Bryant DeSpain
More and more evidence that the NIH (as well as the drug companies, the administration, the de"mock"rat party, and all the supposedly health related organizations are committing and have committed fraud.
Wow, the government owning the vaccine.......do we see anything wrong with his, how this could end up a complete disaster?